about
Recent advances of novel targeted therapy in non-small cell lung cancerEvolutionarily repurposed networks reveal the well-known antifungal drug thiabendazole to be a novel vascular disrupting agentCancer genome landscapesAntiangiogenic therapy for high-grade gliomaCD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivoEMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGFFlexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivoPericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expressionNew insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancerGLO1-A novel amplified gene in human cancerFoxc2 transcription factor: a newly described regulator of angiogenesisAnti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapyNew trends in molecular and cellular biomarker discovery for colorectal cancerRamucirumab in metastatic colorectal cancer: evidence to date and place in therapyOvercoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune DysfunctionVEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedsideBiomarkers of cancer angioprevention for clinical studiesProfile of nintedanib in the treatment of solid tumors: the evidence to dateIndividualized treatment of gastric cancer: Impact of molecular biology and pathohistological featuresBiomarkers of Angiogenesis in Colorectal CancerClinical utility of ramucirumab in advanced gastric cancerCancer stem cells and the tumor microenvironment: interplay in tumor heterogeneityCritical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancersMultikinase inhibitors in the treatment of thyroid cancer: specific role of lenvatinibThe impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic reviewAnti-angiogenic therapies for metastatic colorectal cancer: current and future perspectivesFrom sprouting angiogenesis to erythrocytes generation by cancer stem cells: evolving concepts in tumor microcirculationAngiogenesis in metastatic colorectal cancer and the benefits of targeted therapyInhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesityRegulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatmentPharmacogenetic biomarkers for the prediction of response to antiangiogenic treatmentContemporary use of bevacizumab in ovarian cancerPositron emission tomography to assess hypoxia and perfusion in lung cancerIn vitro and in vivo anti-angiogenic activities of Panduratin ASickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal responseSanguinaria canadensis: Traditional Medicine, Phytochemical Composition, Biological Activities and Current UsesEfficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysisTargeted immune therapy of ovarian cancerAxl is essential for VEGF-A-dependent activation of PI3K/AktTherapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy
P2860
Q21092930-3350890B-08CF-47EB-8BE6-5A5B6AA6C853Q21145736-9D745382-2AD9-4AFD-9045-DA4DFBAE26A3Q22242276-C0CC4E7F-1D8E-4E9D-A9D6-B517F960DE31Q24193485-65738234-26D4-450C-8597-3DBC1FEA974DQ24296427-BCA8135E-B28C-4DAF-A272-905C2D672227Q24310236-15ECF734-2845-4B65-888C-1A1E1B867AD2Q24314412-E72CC8C6-2EB3-4371-AB03-3B0A1F64D31EQ24595357-822C476B-CB8A-4E67-880B-31F8FBD31F55Q24619151-03CC1D2B-1FE2-424A-BA3A-E1EE677D8826Q24631249-BE4A1C37-8332-450E-A060-64010530F3CAQ24653645-596798A1-6AF5-4922-95AE-E542E524B14AQ24655930-6FF6898F-33A6-4957-8747-5C64B8FA46D4Q26739049-86C5CA10-C39F-4F7D-A1CC-E16E18845E9EQ26745418-FCD639E4-3B25-4273-B664-F7B8188EA584Q26749333-BF714F62-5C1A-4DAC-B769-AC57A12A3B89Q26770678-3FE350D1-330B-4F61-A48E-720CF2D723BDQ26774580-E8B706CD-0E0C-426F-AAD7-AE070EE541E0Q26775134-F50E2E52-32DD-47DA-BDD3-803D70AF82B4Q26776198-9A825281-6ABD-4868-BC57-8697512A6E2CQ26778891-AB3EAFB9-F334-4C34-939D-8DCB2F907228Q26785665-30FC7395-4F48-4E18-88DB-7ED55ABBCC59Q26796292-8566D6E2-925F-4482-971D-C3DE8902FB19Q26801289-6DBFCA9C-41F8-4A2A-8428-CE787B027CA0Q26821959-09D3FAFE-AEAA-4F83-B97D-64BF58770A33Q26824086-50412E9B-D7E6-453E-A0C8-AC6A0AB4B58CQ26826817-1747E87C-FBA0-4167-B8D7-09C5062F9D20Q26827148-461F8B74-DEE4-463D-A0E2-5EC3417CC277Q26853604-DF23CE42-FB37-447D-B37E-092BC4407BD0Q26859210-BFD342DA-2233-43E9-9D70-1A263A0B23A5Q26991865-F027BD2D-1F67-41D0-8D46-849469FCBBE4Q26996793-43000F97-2021-4D6C-8492-BE48F187F6F9Q27023510-E9005F19-7E8F-4B0B-9321-7662A31B066FQ27026940-C42FAF6F-513C-426D-AB67-489E9BEC146AQ27301905-E5BAAC93-5AA7-4A56-8A7F-35092687F5F6Q27324518-8EDC1871-3D2C-4331-BAC2-660C7D0B7B25Q28077612-72A50576-00A9-4707-B1AA-8F37E6619DDCQ28079362-6ABE0BB6-95F8-483F-8F95-363962842074Q28082828-7C4E6CE7-BD3D-4956-B837-239BA17B5E88Q28116976-29226628-147D-478B-A4F6-7A600B62F3B6Q28253120-9ECABAD4-7D49-4F74-B6D2-45325DFE094D
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Tumor angiogenesis
@ast
Tumor angiogenesis
@en
type
label
Tumor angiogenesis
@ast
Tumor angiogenesis
@en
prefLabel
Tumor angiogenesis
@ast
Tumor angiogenesis
@en
P2860
P3181
P356
P1476
Tumor angiogenesis
@en
P2093
P2860
P304
P3181
P356
10.1056/NEJMRA0706596
P407
P5008
P577
2008-05-08T00:00:00Z